Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 50801-50850 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05229003
Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC
PHASE2
Recruiting
44 participants
Started: Mar 9, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06293950
Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism
PHASE1
Recruiting
14 participants
Started: Mar 9, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05337189
A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
N/A
Recruiting
482 participants
Started: Mar 9, 2022 · Completed: Apr 30, 2025
4 conditions
2 sponsors
1 location
NCT05275088
Prizvalve® Transcatheter Atrioventricular Valve Replacement Study
NA
Recruiting
15 participants
Started: Mar 9, 2022 · Completed: Jun 10, 2028
2 conditions
2 sponsors
1 location
NCT05220462
Remimazolam vs Midazolam Cognitive and Motor Recovery After Intravenous Conscious Sedation for Dental Extractions.
PHASE3
Recruiting
128 participants
Started: Mar 9, 2022 · Completed: Sep 1, 2024
1 condition
1 sponsor
1 location
NCT05182905
AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
EARLY_PHASE1
Recruiting
97 participants
Started: Mar 9, 2022 · Completed: Sep 30, 2027
4 conditions
4 sponsors
1 location
NCT05260307
Improving Spatial Perception and Speech Understanding in Multitalker Mixtures
NA
Recruiting
220 participants
Started: Mar 9, 2022 · Completed: Nov 30, 2026
1 condition
2 sponsors
1 location
NCT05343325
The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC
PHASE2
Recruiting
25 participants
Started: Mar 9, 2022 · Completed: Mar 31, 2027
2 conditions
2 sponsors
2 locations
NCT05191420
Conversations You Want About Corona Virus Disease (COVID-19)
N/A
Recruiting
23,000 participants
Started: Mar 9, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT05694039
A Prospective Cohort Study On Change of Cognitive Function In Aged-related Hearing Loss With Hearing Aids
NA
Recruiting
388 participants
Started: Mar 9, 2022 · Completed: Mar 9, 2028
4 conditions
1 sponsor
1 location
NCT05188313
TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer
PHASE3
Recruiting
376 participants
Started: Mar 9, 2022 · Completed: Feb 28, 2037
2 conditions
1 sponsor
1 location
NCT05253872
The MELAcare Study: A New Method for Surveillance of Melanoma Patients
NA
Recruiting
378 participants
Started: Mar 9, 2022 · Completed: Mar 31, 2028
1 condition
2 sponsors
1 location
NCT05644457
Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to Treatment in Cancers of the Head and Neck
N/A
Recruiting
50 participants
Started: Mar 9, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT04492605
The Evaluation of TCI378 and TCI507 Probiotics on Weight-lowering Efficacy in Adults
NA
Recruiting
96 participants
Started: Mar 9, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT06561425
A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma
PHASE1/PHASE2
Recruiting
274 participants
Started: Mar 9, 2022 · Completed: Jul 1, 2029
2 conditions
1 sponsor
10 locations
NCT05201781
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
PHASE4
Recruiting
295 participants
Started: Mar 9, 2022 · Completed: Oct 30, 2037
1 condition
1 sponsor
48 locations
NCT05319990
Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)
N/A
Recruiting
100 participants
Started: Mar 9, 2022 · Completed: Dec 31, 2027
5 conditions
2 sponsors
1 location
NCT05856942
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
NA
Recruiting
458 participants
Started: Mar 8, 2022 · Completed: Sep 8, 2025
3 conditions
2 sponsors
1 location
NCT05314738
Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
PHASE1/PHASE2
Recruiting
150 participants
Started: Mar 8, 2022 · Completed: Feb 28, 2026
1 condition
1 sponsor
3 locations
NCT05481164
Newborn Screening for Spinal Muscular Atrophy
N/A
Recruiting
45,000 participants
Started: Mar 8, 2022 · Completed: Mar 7, 2025
1 condition
4 sponsors
8 locations
NCT05333718
Characterization of Type 2 Diabetes Subgroups at Diagnosis: a Necessary Step Towards Precision Medicine in Diabetes.
N/A
Recruiting
1,200 participants
Started: Mar 8, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
2 locations
NCT05100056
A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
N/A
Recruiting
70 participants
Started: Mar 8, 2022 · Completed: Jun 1, 2026
1 condition
1 sponsor
13 locations
NCT06405035
Dissecting the Role of MIcrobioMe in gastroEsophageal Tumor: a multIdisCiplinary Longitudinal Study
N/A
Recruiting
140 participants
Started: Mar 8, 2022 · Completed: Mar 8, 2026
1 condition
1 sponsor
1 location
NCT05087667
Study of the Effectiveness of a Polymer Cerclage System Compared to Cerclages Used in Standard Care (CERCPMCF) )
NA
Recruiting
202 participants
Started: Mar 8, 2022 · Completed: Dec 31, 2028
1 condition
2 sponsors
15 locations
NCT05299944
Reducing Pain and Opioid Use With CBD
PHASE2
Recruiting
150 participants
Started: Mar 8, 2022 · Completed: Feb 28, 2027
1 condition
1 sponsor
2 locations
NCT04643418
Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
81 participants
Started: Mar 8, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05091112
Nerve Composition of Human Lumbar Dorsal Primary Rami and Its Medial Branch
N/A
Recruiting
20 participants
Started: Mar 8, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05295433
An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
PHASE1/PHASE2
Recruiting
63 participants
Started: Mar 8, 2022 · Completed: Apr 2, 2034
1 condition
1 sponsor
12 locations
NCT05245812
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy
NA
Recruiting
90 participants
Started: Mar 8, 2022 · Completed: Feb 28, 2026
2 conditions
1 sponsor
1 location
NCT05353504
Impact of Microbiome-changing Interventions on Food Decision-making
NA
Recruiting
90 participants
Started: Mar 8, 2022 · Completed: Dec 31, 2026
1 condition
4 sponsors
1 location
NCT05078047
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
PHASE3
Recruiting
646 participants
Started: Mar 8, 2022 · Completed: Mar 7, 2027
15 conditions
1 sponsor
40 locations
NCT05292274
NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19
N/A
Recruiting
350 participants
Started: Mar 8, 2022 · Completed: Feb 28, 2026
2 conditions
1 sponsor
1 location
NCT05162118
Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer
PHASE1/PHASE2
Recruiting
51 participants
Started: Mar 8, 2022 · Completed: Dec 22, 2025
1 condition
1 sponsor
1 location
NCT05158361
Acupuncture for Overactive Bladder in Adults
NA
Recruiting
110 participants
Started: Mar 8, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05288127
Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature
PHASE2
Recruiting
55 participants
Started: Mar 8, 2022 · Completed: Nov 30, 2025
2 conditions
5 sponsors
1 location
NCT05225402
Hemodynamic Measurements of Macrocirculatory and Perfusion Parameters in ICU
N/A
Recruiting
45 participants
Started: Mar 8, 2022 · Completed: Dec 30, 2025
3 conditions
2 sponsors
1 location
NCT05847062
Clinical Trial to Analyze Lateralized Models and Medializations of Inverted Arthroplasty.
NA
Recruiting
42 participants
Started: Mar 8, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05248243
Recruitment Assessment in Patients With Acute Respiratory Distress Syndrome and Covid-19
N/A
Recruiting
41 participants
Started: Mar 7, 2022 · Completed: Mar 1, 2025
3 conditions
1 sponsor
1 location
NCT05183763
Medication Adherence Program
NA
Recruiting
402 participants
Started: Mar 7, 2022 · Completed: Apr 30, 2027
3 conditions
4 sponsors
5 locations
NCT05288439
A Study of How Proton Beam Radiotherapy (PBRT) Affects Brain Function and Quality of Life in Children and Young Adults Undergoing Treatment for a Brain Tumor
NA
Recruiting
40 participants
Started: Mar 7, 2022 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT05028062
Naltrexone in AUD Reward Drinkers
PHASE4
Recruiting
60 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2027
2 conditions
2 sponsors
1 location
NCT05657847
Novel Complex Radiodiagnostics of Peripherial Arthropathies
N/A
Recruiting
500 participants
Started: Mar 7, 2022 · Completed: Feb 1, 2027
3 conditions
3 sponsors
3 locations
NCT04538482
DASH INtervention to INvestigate the Gut
NA
Recruiting
112 participants
Started: Mar 7, 2022 · Completed: May 31, 2026
2 conditions
2 sponsors
1 location
NCT07158047
Repeated Far Infrared Sauna Bathing in Adults With Obesity
NA
Recruiting
20 participants
Started: Mar 7, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT04920812
MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases
N/A
Recruiting
66 participants
Started: Mar 7, 2022 · Completed: Sep 7, 2025
1 condition
1 sponsor
9 locations
NCT05462457
TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes
N/A
Recruiting
150 participants
Started: Mar 7, 2022 · Completed: Mar 31, 2032
2 conditions
1 sponsor
1 location
NCT05215808
SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects
PHASE1
Recruiting
72 participants
Started: Mar 7, 2022 · Completed: Sep 30, 2024
1 condition
1 sponsor
6 locations
NCT05144542
Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer
NA
Recruiting
140 participants
Started: Mar 7, 2022 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT05014646
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients
PHASE2
Recruiting
56 participants
Started: Mar 7, 2022 · Completed: Jul 1, 2026
1 condition
2 sponsors
4 locations
NCT06613295
Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy (SABR) Versus SABR Alone for Spinal Metastases
NA
Recruiting
128 participants
Started: Mar 7, 2022 · Completed: Mar 1, 2027
3 conditions
1 sponsor
9 locations
Previous
1
More pages
1014
1015
1016
1017
1018
1019
1020
More pages
1333
Next